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The Place of Renal Scintigraphy in the Diagnosis 
of Renal Artery Stenosis
Fifteen Years of Clinical Experience
Brigit C. van Jaarsveld, MD; Pieta Krijnen, MSc; Frans H. M. Derhc 
Comelis T. Postma. MD. PhD: Maarten A. D. H. Schalekamv. MD. F
Backgrounds Renal scintigraphy with radiolabeled pen- 
tetic acid (diethylenetriamine pentaacetic acid [DTPA]) or, 
more recently, mertiatide (mercaptoacetyltriglycine 
[MAG3] ), with or without captopril challenge, is widely rec­
ommended as a diagnostic test for renal artery stenosis.
Objectives: To address (1) whether the diagnostic ac­
curacy has been improved by the use of captopril and the 
introduction of mertiatide and (2) whether a renal scan 
that shows abnormalities is a useful criterion to select pa­
tients for renal arteriography.
Patients and Methods: A standard diagnostic proto­
col, using both scintigraphy and arteriography, was fol­
lowed in 505 consecutive high-risk hypertensive pa­
tients who were evaluated for renovascular hypertension 
at the University Hospital Dijkzigt, Rotterdam, the Neth­
erlands, from 1978 to 1992.
Results: Renal artery stenosis (^50%) was present in 
263 patients. When the single-lcidney fractional uptake 
was used as a diagnostic criterion, a specificity of 0.90 
was obtained at a cutoff value of 35% for the worst kid­
ney in scintigraphy using pentetic acid without capto­
pril challenge (n=225) and at a cutoff value of 37% after 
captopril challenge (n=280). This was associated with
sensitivity levels of 0.65 and 0.68, respectively. The dif­
ference between the uptake of pentetic acid with and with­
out captopril challenge in the 85 patients who were stud­
ied under both circumstances was no more accurate as a 
predictor of renal artery stenosis. In the 93 patients who 
were studied with mertiatide as well as with pentetic acid, 
both after captopril challenge, the diagnostic accuracy 
was no better with mertiatide than with pentetic acid; mer­
tiatide failed to offer any advantage not only when the 
single-kidney fractional uptake was used as a criterion, 
but also with the use of other scintigraphic parameters 
(eg, time to peak, time to pyelum, overall shape of re­
nographic curve, and kidney size).
Conclusions: The diagnostic accuracy of renal scintig­
raphy has not been improved by the introduction of mer­
tiatide or by the use of captopril. The usefulness of scin­
tigraphy as a diagnostic test for the presence of renal artery 
stenosis remains questionable. The physician will always 
confront either a substantial number of arteriograms that 
do not show abnormalities when renal scintigraphy is omit­
ted as a screening step or a substantial number of missed 
diagnoses when a renal scan that shows abnormalities is 
used as a prerequisite for arteriography.
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HE PLACE of renal scintig- cal that is used.8,11"13 In addition, many cli-
raphy in the diagnosis of re- nicians believe that in a patient with se-
novascular hypertension vere d ru g -re s is ta n t h y p erten sio n ,
has been hotly debated. particularly when this condition is asso-
Scintigraphy is thought to ciated with signs of generalized athero-
be the most reliable noninvasive proce sclerosis, arteriography is warranted irre-
During the past 15 years, all pa­
tients who were evaluated for renovascu-
dure currently available for predicting the spective of whether the renal scan shows 
presence of a clinically significant renal ar- abnormalities, 
tery stenosis.1'10 A renal scan that shows 
abnormalities is therefore used as the ba­
sis for selecting hypertensive patients who lar hypertension at our hypertension cen- 
will require further diagnostic workup with ter underwent both renal scintigraphy and 
renal arteriography. Clinical experience, arteriography. Most of these patients had 
however, shows that the predictive value been referred because of severe hyperten- 
of renal scintigraphy is highly variable, and ' sion that was difficult to treat; some were 
it depends on the selection of patients, on referred because their hypertension was as- 
the criteria by which the renal scans are sociated with generalized atherosclerosis 
analyzed, and on the radiopharmaceuti- or with an abdominal bruit. Our stan-
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MPATIENTS AND METHODS ‘Wi"Tc-mertiatide, data were collected in 10-second frames
during a 20-minute period, and sequential analog images
were obtained every minute, Regions of interest were de- 
This study comprised 505 consecutive high-risk hyperten- lineated by the computer, and an area for background cor- 
sive patients who were referred to the University Hospital rection was placed between the kidneys.14 The single- 
Dijkzigt, Rotterdam, the Netherlands, from 1978 to 1992 kidney contribution to the total renal uptake of the 
for evaluation of possible renovascular hypertension. All radionuclide, measured during the second minute after in­
patients underwent renal scintigraphy and arteriography jection, was expressed as a percentage of the net total of 
according to a standard protocol. The reasons for referral 2-kidney counts (single-kidney fractional uptake). The kid- 
were 1 or more of the following conditions: (1) refractory ney with the lowest uptake was considered to be the kid- 
hypertension (diastolic blood pressure ^95 mm Hg while ney that was most likely to be affected.
receiving 3 antihypertensive drugs) ; (2) severe hyperten- In the patients who were studied with both pentetic
sion (diastolic blood pressure 2:110 mm Hg that was as- acid and mertiatide renography, the following criteria other
sociated with signs of generalized atherosclerotic disease than the single-kidney fractional uptake of radionuclide were
[coronary heart disease and/or intermittent claudica- also analyzed6,14'1'’: (1) visual assessment of kidney size (nor-
tion]); (3) severe hypertension before reaching the age of mal or small); (2) time until activity appeared in the renal
40 years; (4) the presence of an abdominal bruit; or (5) a pelvis, determined by visual evaluation of the 1-minute se-
rise in the serum creatinine level of 20 fxmol/L or greater quential images by the nuclear radiologist (time to py-
( mg/dL) elum); (3) time-to-peak activity (Tnwx [ie, the time until the
The majority of patients had refractory hypertension. None maximal amplitude of the renogram was reached]); (4) the 
of the patients exhibited evidence of endocrine or renal pa- overall pattern of the renographic curve; and (5) interpre- 
renchymal disease. The results of urinalysis and the levels tation by the nuclear radiologist (suspect or not suspect).
The receiver operating characteristic (ROC) curves were 
generated for various parameters of scintigraphy.17
of serum electrolytes, thyrotropin (thyroid-stimulating hor 
mone), and plasma catecholamines were normal; the plasma 
cortisol level showed adequate overnight suppression af- Arteriography was performed via the femoral ap
ter dexamethasone. The serum creatinine level was greater proach. In the vast majority of patients, aortography with
|xmol/L (>1.2 mg/dL) i 
|xmol/L (> 2 .5  mg/dL)
encompassed the following 4 study groups
the digital subtraction technique resulted in adequate vi­
sualization of the renal arteries and their main branches. 
In cases of doubt about the patency of the renal artery, a
(Figure I ): group 1, scintigraphy using pentetic acid with- selective ostial injection of a radiocontrast medium was
out captopril (n= 182) ; group 2, scintigraphy using pen- given. A stenosis was considered to be significant when the
tetic acid both without captopril and following a chal- diameter of the arterial lumen was reduced by 50% ormore.
lenge with 50 mg of captopril at 2 to 8 weeks later (n=85); In patients with bilateral renal artery stenosis, the kidney
group 3, scintigraphy using pentetic acid after a challenge with the most severe stenosis on the arteriogram was re-
with 50 mg of captopril (n= 145) ; and group 4, scintigra- ferred to as the affected kidney. In the same session in which
phy using pentetic acid and mertiatide, performed 2 to 8 arteriography was performed, the effective renal plasma flow
weeks apart, both after captopril challenge (n=93). and glomerular filtration rate (GFR) were determined with
the continuous infusion method using iodohippurate so-
SCINTIGRAPHIC PROCEDURES AND dium I 131 (Hippuran I 131) and thalamate iodine I 125
DATA ANALYSIS and measuring radioactivity in plasma at the steady state.18
In patients who were receiving long-term ACE inhibitor 
treatment, the ACE inhibitor was withheld for at least 24 
hours before scintigraphy was performed. Patients who un­
derwent scintigraphy with captopril challenge received 50 
mg of captopril orally at 1. hour before the examination. 
To ensure adequate absorption of captopril, patients were
STATISTICAL ANALYSES
Data are presented as mean±SD or as the medians and 
ranges, unless stated otherwise. Comparisons of variables 
with a binomial distribution were made using the x- test. 
Comparisons of variables with a normal distribution were
required to fast during the 4 hours preceding scintigra- made using the Student t test and 1-way analysis of vari- 
phy. Sufficient hydration was guaranteed by the oral ad- ance, and comparisons of variables with a skewed distri- 
ministration of 0.5 L of tap water. Blood pressure was mea- bution were made using the Mann-Whitney U test and the
sured with an automatic device (Accutorr 1A and 3, 
Datascope, Datascope Corp, Montvale, NJ) befoi'e admin-
Kruskal-Wallis test. Differences in diagnostic perfor­
mance between scintigraphy using pentetic acid with and
istration of captopril and every 5 to 10 minutes for 2 hours wi thout captopril challenge and between scintigraphy us-
after administration of captopril.
Scintigraphy was performed with the patient in a su­
pine position, and the detector was placed posteriorly. Af­
ter intravenous administration of lWmTc-pentetic acid or
ing pentetic acid and mertiatide were assessed by compar­
ing the areas under the ROC curves.14 Two-tailed P values
less than .05 were considered to indicate statistical signifiMl
canee.
dard practice of always performing arteriography after 
scintigraphy remained constant during this 15-year pe­
riod, although the methods that were used to prepare pa­
tients for scintigraphy and the scintigraphic procedures 
were modified in accordance with prevailing recommen­
dations. From 1978 to 1983, technetium Tc 99m
ntaacetic
[DTPA]) was used for renal scintigraphy. From 1983 to 
1990, the angiotensin-converting enzyme (ACE) inhibi­
tor captopril was administered to enhance the cliagnos-
ARCH INTERN MED/VOL 157, JUNK 9,1997
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tic accuracy of scintigraphy with pentetic acicl.1,2 From 
1990 to 1992,94mTc-pentetic acicl, which is a marker of glo­
merular filtration, was gradually replaced by technetium 
Tc 99m-labeled mertiatide (mercaptoacetyltriglycine [tWmTc- 
MAG3]), which is a marker of renal blood flow.12
Because renal arteriography was always performed af­
ter renal scintigraphy in our center, it was possible for us 
to address the following questions: (1) Have the sensitiv­
ity and specificity of renal scintigraphy been improved by 
the use of captopril? (2) Have the sensitivity and speci­
ficity of scintigraphy been improved by the use of mer­
tiatide instead of pentetic acid? (3) Does our experience 
confirm that a renal scan with abnormalities is a useful cri­
terion for selecting patients for arteriography?
MUH ill
RENAL ARTERIOGRAPHY
Of the total of 505 consecutive patients evaluated for re­
novascular hypertension, renal artery stenosis was shown 
on the arteriograms of 263. The remaining patients were 
considered to have essential hypertension. The prevalence 
of renal artery stenosis in the 4 study groups varied from
Scintigraphy With Pentetic Acid
Scintigraphy
With Mertiatide
Group 1 Group 2 Group 3 Group 4
(n=182) (n=85) (n=145) (n=93)
Scintigraphy Without Captopril Challenge
Scintigraphy With Captopril Challenge
Figure 1. Study groups divided according to scintigraphic procedure.
42% to 55% (Table 1 ). In the overwhelming majority o 
patients with renal artery stenosis (86%), the stenosis wa< 
attributable to atherosclerosis, which was right-sided ir 
66 patients, left-sided in 81, and bilateral in the remain­
ing 78. Bilateral fibromuscular dysplasia was observed ir
16 patients and unilateral asia in 22 patients, 19 o
whom showed right-sided localization. There were minoi 
differences in blood pressure, the serum creatinine level 
GFR, and body mass index (defined as the weight in ki­
lograms divided by the height in meters squared) among 
the 4 study groups, :cs were not imp or
warn in our £tant en
In Table 2
dents with renal artery stenosis are compared with those 
of the subjects with essential hypertension. As expected, 
the patients with renal artery stenosis were 
serum creatinine levels, a lower renal plasma flow, and a 
lower GFR. The somewhat higher body mass index in the 
patients with essential hypertension can be explained by 
the high prevalence of obesity in patients with severe drug- 
resistant essential hypertension;10 The systolic blood pres­
sure was higher in patients with renal artery stenosis, while 
the diastolic blood pressure was equal in both groups.
The number of serious complications caused by ar­
teriography was small. Renal function impairment (se­
rum creatinine level >221 fJumol/L [>2.5 mg/dL] ), which 
was reversible, was seen in 8 patients. One patient had a 
hematoma at the puncture site that required surgical de­
compression. One patient suffered from cholesterol crys­
tal embolization, with livedo reticularis in both legs.
EFFECT OF CAPTOPRIL ON THE RENAL SCAN
Between-Patient Comparison
obtained in the subjects who
,'rwent sein-
***** art*
Table 1. Characteristics of Hypertensive Patients Who Underwent Renal Scintigraphy and Arteriography*
Pentetic Acid
•
Without Captopril and 
Then With 50 mg of After 50 mg
Without Captopril, Captopril 2 to 8 wk Later, of Captopril, With Mertiatide,
Characteristic
Group 1 Group 2 Group 3 Group 4
(0=182) (n*85) (n-145) (n»93) P
Males, % 59 65 62 56 .64
Age, y 51.3±15.1 52.0+12,7 53.9±12.8 52.5+12.8 .39
Body mass index, kg/m2 24,2±4.2 24.8+3.3 24.7±3.5 26.0±5.2 .007
Median serum creatinine level, jxmol/L 105(1.19); 101 (1.14); 
60-269 (0.68-3.04)
120 (1.36); 94(1.06); ■
(mg/dL); range 62-631 (070-7.14) 37-338 (0.42-3,82) 62-309 (0.70-3.50) .005
Serum creatinine level >221 |xmol/L *-
(>2.5 mg/dL), No. of patients 15 2 7 3 .14
Blood pressure at referral, mm Hg
Systolic 190±33 196 ±26 210+30 212+39 <.001
Diastolic 113 ± 16 115+15 124 ± 19 119±18 <.001
Effective renal plasma flow, • ■
mL/min 3191-145 335+123 312±126 349±131 .28
Glomerular filtration rate, . • «
mL/mln 85 ± 25 90±21 79+24 84 ±43 .04
Patients with renal artery stenosis, % 54 55 54 42 .19
mu Ma ■»I—m Mn
* Data are given as mean ± SD, unless Indicated otherwise.
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analysis included groups 1,3, and 4, as well as die patients 
in group 2 who were randomly allocated to group 1 or 3.
In patients with essential hypertension, the single­
kidney fractional uptake of pentetic acid was slightly but 
significantly lower on the left side than on the right side 
during scintigraphy without captopril challenge. The frac­
tional uptake of the kidney with the lowest contribu­
tion to the total renal uptake was not altered by capto­
pril challenge (Table 3). In patients with renal artery 
stenosis, the single-kidney fractional uptake on the af­
fected side was reduced compared with that in subjects 
with essential hypertension. The asymmetry between the 
2 kidneys was therefore increased in patients with renal 
artery stenosis, but the asymmetry was not affected by 
captopril challenge (Table 3).
The ROC curves were generated for the kidney with 
the lowest uptake, and the ROC curve for scintigraphy 
using pentetic acid without captopril challenge was com­
pared with the ROC curve for scintigraphy after capto­
pril challenge (Figure 2). There was no difference be­
tween the areas under the 2 curves 0 .84±0.03 vs 
0.84±0.02, respectively). Because a high specificity is re­
quired for the diagnosis of renal artery stenosis, the op-
Table 2. Characteristics of Patients With Essential 
Hypertension and Renal Artery Stenosis*
Characteristic
Essential
Hypertension
(ns242)
Renal Artery 
Stenosis 
(n»263) P
Males, % 57 64 .10
Age, y 49.4 ±12.8 55.1 ±13.9 <.001
Body mass Index, kg/m8 26.0±3.9 23.7±4.0 <,001
MoOian serum
creatinine level, 91 (1.03); 
37-423
121(1.37);
iimol/L (mg/dL); 60-631
range (0.42-4.79) (0.68-7.14) <.001
Blood pressure 
at referral, mm Hg
Systolic 194±35 202±30 ,02
Diastolic 117±19 116±16 .73
Effective renal
plasma flow, ml/min 381 ±135 272±110 <.001
Glomerular filtration rate,
mL/min 93±28 76 ±24 <.001
* Data are given as meant, SD, unless Indicated otherwise.
timal cutoff point for a positive test was determined as 
the value that corresponded with a specificity of 0.90. For 
the whole group, a specificity of 0.90 was obtained at a 
cutoff value of 35% (single-kidney fractional uptake ^35% 
was considered suspect for renal artery stenosis) with­
out captopril challenge and at a cutoff value of 37% with 
captopril challenge (Table 4). This was associated with 
a sensitivity of 0.65 and 0.68, respectively. Data were also 
analyzed separately for unilateral and bilateral stenosis 
because, in bilateral stenosis, a decrease in the frac­
tional uptake on the less-affected side after captopril chal-
might have obscured between the
* sensitivity was indeed somewhat 
daterai stenosis than for bilateral e* -
ofsein
tigr ly with pentetic acid in either group.
Within-Fa tient Comparison
: group o
underwent scintigraphy using pentetic acid both with­
out and after captopril challenge (group 2). The kidney 
with the lowest uptake during scintigraphy using pen­
tetic acicl without captopril challenge was compared with 
the same kidney after captopril challenge. The effect of 
captopril was analyzed by subtracting the single-kidney 
fractional uptake of pentetic acid after captopril chal­
lenge from the uptake without captopril challenge. The 
results are shown in Figure 3.
In 4 patients, the kidney with the lowest uptake con­
tributed 10% or less to the total renal uptake during scin­
tigraphy using pentetic acid without captopril chal­
lenge. As expected, captopril did not change the fractional 
uptake by these kidneys. These patients were therefore
excluded from the analysis presented in Figure 3. T 
optimal cutoff point for a positive test, corresponding to 
a specificity of 0.90, was a value of 5% for the difference
**■
tetic acid without captopril challenge and scintigraphy
s was
raphy with pentetic
.64. Thus, dual sc
in which I renal scan was ta»
offer any advantage over s
Mige or wi
Table 3. Between-Patient Comparison of Single-Kidney Fractional Uptake 
in Scintigraphy Using Pentetic Acid With and Without Captopril Challenge*
Essential Hypertension, % Contribution Renal Artery Stenosis, % Contribution
r
R Kidney L
Kidney With Kidney With 
Contralateral Kidney Lowest
(n*225) 53.6±9.11 46.4*9.1 43.1 ±6,9 25,1+17.0  ^ 74.9±17.0 24.6±16.4§
s 50.9±8,1 49.1 ±8.1 44,0±5vl 27»fc16, I W4
*Data are given as mean±SD. The contribution of the kidney with the lowest uptake without captopril challenge was not significantly different from the 
contribution after captopril challenge (P-.28 for essential hypertension; P=.14 for renal artery stenosis). 
fP<.001 for difference relative to left kidney.
^P< .001 for difference relative to contralateral kidney.
§P<.001 for difference relative to essential hypertension.
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Figure 2. The receiver operating characteristic curves for the single-kidney 
fractional uptake in scintigraphy using pentetic acid with and without 
captopril challenge.
It has been well documented that the number of false- 
negative tests in scintigraphy with pentetic acid can be 
reduced by the use of captopril.3,8,21,22 In our series, this 
was the case in 12 of the 29 patients with unilateral ste­
nosis and in 4 of the 17 patients with bilateral stenosis. 
However, in 3 patients with unilateral stenosis and in 3 
patients with bilateral stenosis, the test remained nega­
tive after captopril challenge. Moreover, in some pa­
tients with essential hypertension, the test became posi­
tive after captopril challenge or was positive both with 
and without captopril challenge. Thus, although the use 
of captopril can improve the diagnostic accuracy of scin­
tigraphy with pentetic acid in individual cases, this is not 
a uniform finding; in fact, captopril may increase the num­
ber of false-positive tests.
SCINTIGRAPHY WITH MERTIATIDE, VS
PENTETIC ACID
Between-Patient Comparison
The scintigraphy with mertiatide was always performed 
after captopril challenge. Results of the scintigraphy with 
mertiatide were therefore compared with those of scin­
tigraphy with pentetic acid after captopril challenge. The 
analysis included groups 2, 3, and 4.
A striking difference between the renal scans with 
mertiatide and pentetic acid was the diminished asym­
metry between the 2 kidneys that was observed on the 
scans with mertiatide in patients with renal artery ste­
nosis (Table 5). Again, the ROC curves were generated 
for the kidney with the lowest uptake. A specificity of 
0.90 was obtained at a cutoff value of 35% for the single- 
kidney fractional uptake both with mertiatide and pen­
tetic acid scintigraphy. This specificity was associated with 
a sensitivity of 0.42 for mertiatide and 0.69 for pentetic 
acid. Thus, when the single-kidney fractional uptake was
»UPM!
Table 4. Between-Patient Comparison of Scintigraphy 
Using Pentetic Acid With and Without Captopril Challenge*
Comparison
Captopril
Challenge
Cutoff Value
Sensitivity Specificity for SKFU, %
EHT vs RAS
EHT vs URAS
EHT vs BI RAS
No
Yes
No
Yes
No
Yes
0.65 0.90 35
0.68 0.90 37
0.70 0.90 35
0.73 0.90 37
0.63 0.90 35
0.58 0.90 38
■*»
*EHT indicates essential hypertension (n=242); RAS, renal artery 
stenosis (n=263); URAS, unilateral renal artery stenosis (n=169); BIRAS, 
bilateral renal artery stenosis (n=94); and SKFU, single-kidney fractional 
uptake.
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Figure 3. Effect of captopril on the single-kidney fractional uptake in 
scintigraphy using pentetic acid.
taken as the test criterion, scintigraphy with pentetic acid 
was superior to that with mertiatide.
Within-Patient Comparison
This analysis was limited to the patients who under­
went scintigraphy with mertiatide as well as that with pen­
tetic acid, both after captopril challenge (group 4). A speci­
ficity of 0.90 was obtained at a cutoff value of 36% for 
the single-kidney fractional uptake with scintigraphy us­
ing mertiatide and at a cutoff value of 38% with scintig­
raphy using pentetic acid. This was associated with a sen­
sitivity of 0.42 for mertiatide and 0.61 for pentetic acid. 
These results are similar to those of the larger between- 
patient analysis.
In the interpretation of renal scans with mertiatide, 
parameters other than the single-kidney fractional up­
take might be better discriminators for the presence or 
absence of renal artery stenosis. Table 6 provides data 
on the diagnostic accuracy of the single-kidney frac­
tional uptake, as well as other scintigraphic parameters 
(ie, [Tm;lx], time to pyelum, overall pattern of the reno-
ARCH INTERN ME D/VO I. 157, JUNE 9,
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* * * * *
• p* » * ?
* * * * *
5. Between Kidney Fractional Uptake in Scintigraphy With Pentetic Acid and MAG:*
Essential , % Contribution
Type of 
Scintigraphy
Renal Artery Stenosis, % Contribution
L
Kidney With
514*7.9 48.6+7.9 44.0 ±5.3
I • V ' 43.5 i l l
*Data are given as mean±SD.
fP<.001 for difference relative to contralateral kidney.
$P<.0Q1 for difference relative to essential hypertension.
§P<.001 for difference relative to scintigraphy with pentetic acid.
1----- ................... . ■ ..........................................................1
Kidney With
Affected Kidney Contralateral Kidney Lowest Uptake
24.4 ±16.8f 75.6 ±16.8 
36.5±12.2f§ 63.5 ±12.2
24.2±16.5^ :
36J±12J$§
m mmmtwmi mmm
Acid and Mertiatide Scintigraphy, Both After Captopril
*
0.55 0.76 0.50
0.68
0.63
0.61
0.54
0.70
0.85
0.87
0.93
0.50
0,58
0.53
.68 0, \t m '..t
0.61 0.98
&7 mln .66
0.53
0.78
0.80
0.66
0.63
0.61 0.87 0,
Pattern of
0.76 0,63
0.66 0.91
0.66 0.93 0.61
0.
11 • M* f •
0.82
0.89
.89
.98
0.96
0.44
0.67
0.84
0.86
0.80
0.89
96
* SKFU Indicates single-kidney fractional uptake; TTP, time to pyelum; and 
Tffux, time to peak. 
tAbsolute difference between the kidneys in TTP or Tm. 
iRenographic curve type 2 represents delayed excretion with preserved 
washout; curves type 0 and 1, the normal excretion pattern or minor 
abnormalities, respectively; and curve types 3, 4, and 5, delayed excretion 
rate without washout phase, renal failure pattern with measurable kidney 
uptake, and renal failure without measurable kidney uptake, respectively 
(adapted from Fommei et al6).
ference in the diagnostic accuracy of these parameters. 
Nevertheless, if the test result was based on the Tninx and 
time to pyelum rather than the single-kidney fractional 
uptake, scintigraphy with mertiatide was still not supe­
rior to that with pentetic acid.
COMMENT
STUDY STRENGTHS AND LIMITATIONS
-mertiatide in
Renal scintigraphy is widely used in the diagnostic workup 
of renovascular hypertension. This report summarizes our 
experience with the technique from 1978 to 1992. Dur­
ing this period, 2 major modifications were introduced 
in many clinical centers, including ours (ie, the use of 
the ACE inhibitor captopril to enhance the difference be­
tween the affected and nonaffected kidney, and the use 
of the new radiopharmaceutical, 
stead of tH)mTc-pentetic acid.
The numbers of hyper tensive patients with and with­
out renal artery stenosis who were included in our analy­
sis of the effect of captopril on the renal scan with pentetic 
acid far exceeded those reported in most previously pub­
lished studies. The European multicenter study by Fom­
mei et al6 is the only study that we know of that included 
a comparable number of patients. To our knowledge, the 
comparison of scintigraphy using mertiatide with scintig­
raphy using pentetic acid in our study represents the first 
systematic within-patient analysis in a substantial number 
of patients, in contrast to other studies that have been re­
ported to date and that have dealt with only small numbers 
of patients.13,21,23 Clinical characteristics of the patients in 
our study are comparable with those in other studies.1,5,20
Because our analysis is retrospective, confounding 
factors (particularly changes over time in the selection 
of patients and in the evaluation of renal scans) could 
not be as well controlled as in a prospective study, This
difficulty was in part overcome by (1) studying a large 
series of consecutive patients in whom both arteriogra­
phy and scintigraphy were systematically performed, 
(2) comparing the different scintigraphic procedures in 
the same patient within a short time interval, and (3) us­
ing objective criteria for evaluating the scintiscans.
This report addresses the use of renal scintigraphy 
uptake; however, with pentetic acid, there was little dif- as a screening procedure, prior to arteriography, to di­
graphic curve, and kidney size) in both mertiatide and 
pentetic acid scintigraphy. These data show that, in­
deed, with the use of mertiatide, the Tmax and time to py­
elum are better criteria than the single-kiclney fractional
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agnose the presence of renal arteiy stenosis. Renal ar­
tery stenosis does not equal renovascular hypertension. 
Essential hypertension is common, and in some pa­
tients with renal artery stenosis, the stenosis may not be 
responsible for the hypertension.
So-called 2-kidney 1-clip Goldblatt hypertension in
the use of broader categories (eg, <50% 
<60% vs 2:60%), the agreement between
5> t>, O!
rent radi­
ologists is better, but it is slill far from complete.2V,2M h
practice, ■e, it is
50% and 60% stenosis with the le
*r
raphy that are routinely used in most hospitals. The 50^
animals, which serves as the experimental model of hu- stenosis criterion that we used in this report is also wide!)
J *   ^ t j PD â % % 'I
man renovascular hypertension, is generally held to pro­
ceed in 2, sometimes 3, phases.24 In the early first phase, 
the rise in blood pressure is largely, if not completely, caused 
by the rise in the levels of circulating renin and angioten­
sin II. In the second phase, the blood pressure remains high, 
although the levels of renin and angiotensin II return to­
ward normal. This may be due, at least partly, to the fact 
that a slightly elevated angiotensin II level, chroni­
cally present, reinforces its own pressor action. In this phase, 
the secretion of renin from the clipped kidney is still stimu­
lated, and the function of this kidney is highly dependent 
on angiotensin II. This, in the human equivalent, is illus­
trated by the increased renal venous renin level on the af­
fected side and the suppressed renin level contralaterally 
(increased renal vein—renin ratio), by the increased re­
sponse of peripheral venous renin to the administration 
of captopril (positive captopril-renin test), and by the ef­
fects of this drug on the renal handling of pentetic acid 
and mertiatide (abnormal scan with captopril). In both the 
first and second phases of 2-kidney 1-clip Goldblatt hy­
pertension, relief of the stenosis will lead to relief of the 
hypertension. This is no longer the case in the third and 
last phase, possibly because of structural changes in the 
contralateral kidney.
Renovascular hypertension in humans is often de­
fined as being characterized not only by the presence of 
renal artery stenosis but also by the cure of the hyper­
tension after repair of the stenosis. However, some pa­
tients may be in an advanced stage, analogous to the third 
phase of 2-kidney 1-clip Goldblatt hypertension, and are 
therefore not cured by the use of balloon angioplasty or 
reconstructive surgery. Persistence of the hypertension 
may also reflect technical failure or recurrence of the ste­
nosis after angioplasty. The most important objection to 
the use of the blood pressure response to balloon angi­
oplasty or reconstructive surgery as a basis for defining 
renovascular hypertension is that it is a diagnosis a pos­
teriori and therefore not helpful clinically.
In this report, renal artery stenosis was defined as a 
reduction of 50% or more of the arterial lumen diameter 
on the arteriogram. Based on the experimental studies 
of 2-kiclney 1-clip Goldblatt hypertension, it may be sug­
gested that a more severe stenosis (ie, 2:60% or 2:70%) 
of the renal artery might be a better definition. How­
ever, to our knowledge, this has never been formally tested 
in clinical studies. Moreover, accurate assessment of the 
degree of stenosis is difficult in the absence of 3-dimen­
sional images, particularly when the lesions are irregu­
lar and eccentric.25 Most important, the radiologist’s in­
terpretation of renal arteriograms shows considerable 
interobserver variability. When experienced radiolo­
gists are asked to distinguish among no stenosis, less than 
50% stenosis, 50% to 75% stenosis, 76% to 99% steno­
sis, and occlusion, their interpretations of the arterio­
grams show poor agreement ( k  values, 0.33-0.48).26 With
used in the literature. l(',2‘s"27,iy"u
This report does not assess the usefulness of renal sein 
tigraphy to predict the outcome of balloon angioplasty oi 
reconstructive surgery. A retrospective study, such as ours 
is not suitable lor such an assessment, because of the lad 
of systematic follow-up data on blood pressure after the 
intervention, the lack of a standardized protocol for anti­
hypertensive drug treatment, and the difficulty to define 
“improvement” after intervention.15
EFFECTS OF CAPTOPRIL ON SCINTIGRAPHY
WITH PENTETIC ACID
The importance of the renin-angiotensin system for main­
taining the GFR, when renal perfusion is compromised b) 
artery stenosis, has been demonstrated in animal studies 
and is also illustrated by clinical observations. The GFF 
is maintained through angiotensin 11-mediated efferent ar 
teriolar constriction. Impairment of renal function aftei 
blockade of angiotensin II formation by ACE inhibitior 
has been documented in patients with artery stenosis of £ 
solitary functioning kidney and in bilateral stenosis. In pa­
tients with unilateral stenosis, the percent renal extrac­
tion of arterially delivered 125l-labeled thalamate, whicl 
is a measure of the filtration fraction, is reduced by cap­
topril, and much more so on the affected than the unaf­
fected side.18 Captopril also affects the scans with pen­
tetic
curve of such a kidney is characterized by a less steep up­
take phase, a later peak, and a flatter downslope in the ex­
cretion phase compared with that of the unaffected kid­
ney. These abnormalities are often reinforced by captopri 
or become m
The single-kidney contribution to the total renal ac­
cumulation of pentetic acid during the uptake phase af­
ter injection is commonly used as a diagnostic crilerior
(single-kidney fractional uptake).1 w ,n’ Like other in­
vestigators, we observed a decrease in the single-kidne) 
fractional uptake after captopril challenge on the af­
fected side in patients with renal artery stenosis, so tha 
a normal fractional uptake without captopril became ab
îe. However, this was nonormal
a uniform finding. In some patients, the single-kidney 
fractional uptake on the affected side was normal botl 
with and without captopril. Moreover, in some patient; 
with essential hypertension, the normal fractional up 
take without captopril became abnormal after captopri 
challenge. On average, with the single-kidney fractiona 
uptake as the diagnostic criterion, the accuracy of sein 
tigraphy with pentetic acid was not improved by capto 
pril challenge in our series.
Other criteria, Tnulx, time to pyelum, the overall pat 
tern of the renographic curve, and kidney size, ap 
peared to offer no advantages over the single-kidney frac 
tional uptake. In the European multicenter study of thi
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effects of captopril on the renal scan with pentetic acid , 
the sensitivity (at a specificity of approximately 0.90) was 
0.61 without captopril challenge and 0.70 after capto­
pril challenge with the single-kidney fractional uptake 
as the criterion.6 For the Tmax, the sensitivity in that study 
was only 0.39 without captopril and 0.77 after captopril 
challenge. The European study also showed that the 
change in the single-kiclney fractional uptake caused by 
captopril challenge was not a more accurate parameter 
for predicting renal artery stenosis. The findings of our 
study are in agreement with these results.
MERTIATIDE VS PENTETIC ACID
A noteworthy finding in the present study is that the single­
kidney fractional uptake on the affected side was higher 
with mertiatide than with pentetic acid in patients with 
renal artery stenosis, so that the difference in uptake be­
tween the affected kidney and contralateral kidney was 
smaller with mertiatide than with pentetic acid. This may 
be related to the use of captopril in our comparative analy­
sis; mertiatide is cleared by the kidney mainly by tubular 
secretion, whereas pentetic acid is cleared by glomerular 
filtration. The renal clearance of mertiatide is a measure 
of renal blood flow, whereas the renal clearance of pen­
tetic acid is a measure of glomerular filtration. In the kid­
ney with artery stenosis, captopril has a proportionally 
larger effect on the GFR than on renal blood flow; in fact, 
flow may even increase after captopril challenge. These dif­
ferential effects on filtration and flow are reflected in the 
decrease in the percent renal extraction of arterially de­
livered 125I-thalamate, which equals the filtration frac­
tion.18 Thus, captopril may cause a greater fall in the single­
kidney fractional uptake with pentetic acid than with 
mertiatide. We are not aware of any study in which this 
issue has been systematically addressed. A practical con­
sequence of the smaller difference in uptake between the 
affected kidney and the contralateral kidney with mer­
tiatide than with pentetic acid is the lower accuracy of scin­
tigraphy with mertiatide when the single-kidney frac­
tional uptake is used as a diagnostic criterion.
Like other investigators, we found the Tmax in scin­
tigraphy with mertiatide to be a better criterion than the 
single-kidney fractional uptake. However, our results show 
that the use of this criterion in scintigraphy with mer­
tiatide still did not lead to a higher diagnostic accuracy 
than could be obtained with scintigraphy with pentetic 
acid. Our comparison between mertiatide and pentetic 
acid was limited to patients who were studied after cap­
topril challenge. In view of our observations on the ef­
fects of captopril on the renal scan with pentetic acid, it 
seems unlikely that the diagnostic accuracy with mer­
tiatide would be superior to that with pentetic acid in 
patients who were not challenged with captopril.
Better images are produced with mertiatide than with 
pentetic acid in patients with impaired renal function. 
According to the Working Party Group on Determining 
the Radionuclide of Choice,41 the use of pentetic acid is 
not recommended in patients with a serum creatinine level 
greater than 442 pimol/L (>5.0 mg/dL), and pentetic acid 
should be used with care if the serum creatinine level is 
greater than 221 (xmol/L (>2.5 mg/dL). The number of
such patients in our study was too small to address this 
point.
DIAGNOSTIC VALUE OF RENAL SCINTIGRAPHY
The prevalence of renal artery stenosis among the gen­
eral population of hypertensive patients is low, ranging 
from 1% to 5%.32 Because renal arteriography is inva­
sive and not without risk, renal scintigraphy has been ad­
vocated as a screening procedure to select patients for 
arteriography. To avoid an unacceptably high number of 
arteriograms with no abnormalities, the diagnostic speci­
ficity of renal scintigraphy must be high. In the present 
analysis, we chose test results that corresponded with a 
specificity of 0.90 as cutoff points for a positive test. At 
this level of specificity, the sensitivity of scintigraphy with 
pentetic acid ranged from only 0.61 to 0.68, depending 
on the renographic parameters (ie, single-kidney frac­
tional uptake, Tmax, time to pyelum, overall shape of re­
nographic curve) that were used. The diagnostic accu­
racy of scintigraphy using mertiatide with captopril 
challenge was no better.
Given a test sensitivity of 0.68 and a specificity of
0.90 and assuming a 3% prevalence of renal artery ste­
nosis among the total population of hypertensive pa­
tients, then to detect 20 cases in a population of 1000, 
only 117 subjects need to undergo arteriography if a re­
nal scan with abnormalities is used as a selection crite­
rion for arteriography, whereas 667 subjects will un­
dergo arteriography if scintigraphy is omitted. However, 
if a renal scan with abnormalities is used as a selection 
criterion for arteriography, 10 cases of renal artery ste­
nosis will be missed. Obviously, in a population with such 
a low prevalence, one has little choice but to perform scin­
tigraphy, since it is not practical to perform arteriogra­
phy in such large numbers of subjects.
Two strategies can be followed as an alternative to 
scintigraphy. One is the introduction of well-defined and 
sensible clinical criteria to identify high-risk patients. Prac­
tical criteria would need to be strict enough to reduce 
the number of arteriograms to an acceptable level, but 
not so rigid as to miss too many cases. The other is the 
development of less invasive techniques to visualize the 
renal arteries as a replacement for arteriography (eg, mag­
netic resonance angiography, spiral computed tomogra­
phy, or duplex ultrasonography). The question of whether 
much harm is being done by withholding balloon dila­
tion or surgical revascularization from a patient who will 
otherwise need lifelong intensive antihypertensive drug 
treatment also remains to be answered. Recent reports 
suggest that a renal scan that shows abnormalities may 
be associated with a higher chance of a favorable out­
come of nonmedical intervention procedures, but it is not 
certain whether a renal scan that does not show abnor­
malities is a strong enough reason to refrain from such 
interventions.6,34’36’38 A prospective study addressing pre­
cisely these issues is now being carried out in the Neth­
erlands.42 In this multicenter study, strictly controlled stan­
dard drug regimens are being used to define refractory 
hypertension, a standardized protocol for the diagnos­
tic workup is being followed, and the effects of balloon 
dilation and drug therapy are being compared.
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Currently, scintigraphy is still the most effective di­
agnostic procedure to reduce the number of arterio­
grams without abnormalities to a level that is acceptable 
in terms of burden to the patient and cost. Therefore, when 
dealing with a population of patients with a low preva­
lence of renal artery stenosis, it is good policy to per­
form scintigraphy before deciding to proceed with arte­
riography. On the other hand, when the prevalence of 
renal artery stenosis is high, it is reasonable to omit scin­
tigraphy and proceed directly with arteriography. In prac­
tice, the omission of renal scintigraphy as a screening step 
will always result in a substantial number of arterio­
grams that do not show abnormalities, whereas the use 
of a renal scan that does show abnormalities as a selec­
tion criterion for arteriography will always result in a sub­
stantial number of missed diagnoses.
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